Published “Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer” in New England Journal of Medicine — cited 1,746 times.
- #crossref
- #research
- #work
Published “Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer” in New England Journal of Medicine — cited 1,746 times.
Captured 2026-08-24 from Crossref. The archived copy is preserved so this citation survives link rot.